Fiscal Year 2020
Released March, 2019
Topics on this page: Regulatory Reform
Regulatory Reform
On April 28, 2017, the Administration published OMB Memorandum M-17-23, Regulatory Reform Officers and Regulatory Policy Officers at Executive Departments and Agencies. HHS currently tracks progress on six regulatory reform measures.
Number of evaluations to identify potential EO 13771 deregulatory actions that included opportunities for public input and/or peer review (RR1)
| Measure | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Target | N/A | N/A | N/A | N/A | 44 | 12 | TBD |
| Result | N/A | N/A | N/A | N/A | 111 | 10/31/19 | 10/31/20 |
| Status | N/A | N/A | N/A | N/A | Target Exceeded | Pending | Pending |
During FY 2017 and 2018, the Department worked to identify 155 deregulatory actions. For this reason, the number of evaluations has decreased from 1 to 2 new evaluations each month in FY 2019.
Number of EO 13771 deregulatory actions recommended by the Regulatory Reform Task Force to the agency head, consistent with applicable law (RR2)
| Measure | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Target | N/A | N/A | N/A | N/A | 19 | 30 | TBD |
| Result | N/A | N/A | N/A | N/A | 61 | 10/31/19 | 10/31/20 |
| Status | N/A | N/A | N/A | N/A | Target Exceeded | Pending | Pending |
In FY 2017 and 2018, HHS Regulatory Reform Task Force working groups identified 155 deregulatory actions. The Task Force recommended 80 of those actions. Of the 75 remaining deregulatory actions, HHS predicts that the Task Force will approve 30 actions. Some of the submitted actions are not deregulatory based on EO definitions. Other deregulatory actions will require more detail before the Task Force can make a recommendation.
Number of EO 13771 deregulatory actions issued that address recommendations by the Regulatory Reform Task Force (final/published) (RR3)
| Measure | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Target | N/A | N/A | N/A | N/A | 4 | 34 | TBD |
| Result | N/A | N/A | N/A | N/A | 25 | 10/31/19 | 10/31/20 |
| Status | N/A | N/A | N/A | N/A | Target Exceeded | Pending | Pending |
Based on the HHS FY 13771 Cost Allocation submitted to OMB, the Department expects to finalize 34 deregulatory actions in FY 2019. The Regulatory Reform Task Force recommended all deregulatory actions appearing on the HHS FY 2019 13771 Cost Allocation table.
Number of EO 13771 regulatory actions issued (final/published) (RR4a)
| Measure | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Target | N/A | N/A | N/A | N/A | 6 | 15 | TBD |
| Result | N/A | N/A | N/A | N/A | 4 | 10/31/19 | 10/31/20 |
| Status | N/A | N/A | N/A | N/A | Target Exceeded | Pending | Pending |
Based on the HHS FY 13771 Cost Allocation table submitted, the Department expects to finalize 15 regulations in FY 2019.
Number of EO 13771 deregulatory actions issued (final/published) (RR4b)
| Measure | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Target | N/A | N/A | N/A | N/A | 16 | 34 | TBD |
| Result | N/A | N/A | N/A | N/A | 25 | 10/31/19 | 10/31/20 |
| Status | N/A | N/A | N/A | N/A | Target Exceeded | Pending | Pending |
Based on the HHS FY 13771 Cost Allocation table submitted, the Department expects to finalize 34 deregulatory actions in FY 2019.
Total incremental cost of all EO 13771 regulatory actions and EO 13771 deregulatory actions (RR5)
| Measure | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Target | N/A | N/A | N/A | N/A | -$28.7 million | -$550 million | TBD |
| Result | N/A | N/A | N/A | N/A | -$763.48 million | 10/31/19 | 10/31/20 |
| Status | N/A | N/A | N/A | N/A | Target Exceeded | Pending | Pending |
In FY 2019, the Department expects to decrease total incremental cost by $550 million in annualized dollars.
